Innoviva SEC Filings

Innoviva, Inc. (INVA) reported insider equity activity. The reporting person acquired 110,436 shares of common stock at $18.11 on November 3, 2025, noted as a time‑vested RSU grant. 25% vests on November 20, 2026, with the remainder vesting in 12 substantially equal quarterly installments, subject to continuous service, with accelerated vesting upon specified change‑in‑control conditions.

The filing also shows 1,860 shares acquired at $0 under the Employee Stock Purchase Plan on May 15, 2025. Following the reported transactions, the reporting person beneficially owned 162,276 shares directly.

Innoviva, Inc. reported stronger Q3 2025 results. Total revenue for the three months ended September 30, 2025 was $107.8 million, up from $89.5 million a year ago, driven by $59.9 million in royalty revenue and $47.3 million in net product sales. Net income rose to $89.9 million (diluted EPS $1.08) from $1.2 million (diluted EPS $0.02) in Q3 2024, aided by gains in the fair values of investments.

Year-to-date through Q3 2025, revenue reached $296.7 million with net income of $107.0 million. Cash and cash equivalents were $476.5 million as of September 30, 2025, supported by $142.4 million in operating cash flow for the nine-month period. The company eliminated its current balance on the 2025 convertible notes through conversions totaling $192.5 million to common stock, while long-term debt stood at $257.4 million. Common shares outstanding were 74,769,062 as of October 31, 2025.

Innoviva, Inc. (INVA) furnished an 8-K announcing its quarterly results press release. On November 5, 2025, the company provided a press release covering results for the quarter ended September 30, 2025, attached as Exhibit 99.1. The disclosure under Item 2.02 is furnished, not filed, and is not subject to Section 18 liabilities, nor incorporated by reference unless specifically stated.

Bank of Nova Scotia filed an amended Schedule 13G reporting beneficial ownership of 2,179,005 shares of Innoviva, Inc. common stock, representing 3.37% of the class as of the reporting event date 09/30/2025. The filing shows the bank has sole voting and sole dispositive power over all reported shares and does not report shared voting or dispositive power. The filing identifies the filer as a parent holding company organized in Canada and includes a certification about comparable foreign regulatory oversight. No larger group affiliation, transfers on behalf of others, or ownership above 5% are reported.

Bank of Nova Scotia reported ownership of 3,585,830 shares of Innoviva, Inc. common stock, representing 5.55% of the class, on a Schedule 13G/A filing. The bank identifies itself as a parent holding company organized in Canada and states the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Innoviva. The filing lists sole voting and dispositive power over the reported shares and supplies Innoviva's principal executive office address.

Insider sale via tax-withholding reduced holdings. Innoviva CFO Stephen Basso reported a disposition of 237 shares of Common Stock on 08/20/2025 at a reported price of $19.95 per share. The filing states the shares were withheld by the issuer to satisfy income tax withholding obligations tied to the quarterly vesting of previously granted employee equity awards. After the transaction Mr. Basso beneficially owned 23,281 shares directly. The form is signed and dated 08/22/2025.

Marianne Zhen, Chief Accounting Officer of Innoviva, Inc. (INVA), reported a disposition of company stock on 08/20/2025. The Form 4 shows 991 shares were disposed at a price of $19.95 per share, leaving 49,329 shares beneficially owned after the transaction. The filing explains the shares were withheld by the issuer to satisfy income tax withholding related to the quarterly vesting of previously granted employee equity awards.

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation report beneficial ownership of 4,760,832 shares of Innoviva, Inc. common stock (CUSIP 45781M101), representing 7.56% of the outstanding class. The filing shows the reporting persons have sole voting and sole dispositive power over these shares. The statement is made on a Schedule 13G/A and includes a certification that the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. Certain funds managed by Renaissance may have rights to dividends or sale proceeds related to these securities.